Chronic kidney disease (CKD) significantly contributes to the global burden of noncommunicable diseases (NCDs). CKD dramatically increases cardiovascular mortality risk and worsens outcomes for individuals with diabetes and hypertension. Affecting 5-7% of the global population, milder forms of CKD, often stemming from diabetes and hypertension, are prevalent, particularly in developing nations and disadvantaged communities. Early detection and intervention are crucial.
Simple, affordable treatments can slow CKD progression to end-stage renal disease (ESRD). Targeting CKD, specifically reducing urine protein, offers effective and cost-efficient improvements in cardiovascular and kidney health, especially for high-risk populations. Incorporating these strategies into existing NCD programs can lessen the demand for renal replacement therapy.
Early diagnosis and treatment, achievable with minimal expense, can alleviate the ESRD burden, enhance outcomes for diabetes and cardiovascular disease (including hypertension), and substantially decrease NCD-related illness and death. When developing and implementing national NCD policies, both developed and developing countries must prioritize CKD prevention.
Addressing CKD is essential in the fight against NCDs. Its impact on major NCDs like cardiovascular disease and diabetes necessitates proactive measures. Integrating CKD prevention and management into broader NCD strategies offers a significant opportunity to improve global health outcomes.
Early detection and treatment are cost-effective solutions that can significantly reduce the need for expensive and resource-intensive interventions like dialysis and transplantation. By prioritizing CKD, nations can make significant strides in reducing the overall burden of NCDs.
